EA201600409A1 - RED ANTRAKHINON GROUP PIGMENT, METHOD FOR OBTAINING RED STRAIN PIGMENT PENICILLIUM OXALICUM VAR. ARMENIACA, PRODUCT OF THE METHOD, ITS APPLICATION, PHARMACEUTICAL COMPOSITION AND METHOD OF PREVENTION AND / OR TREATMENT OF ONCOLOGICAL DISEASES - Google Patents

RED ANTRAKHINON GROUP PIGMENT, METHOD FOR OBTAINING RED STRAIN PIGMENT PENICILLIUM OXALICUM VAR. ARMENIACA, PRODUCT OF THE METHOD, ITS APPLICATION, PHARMACEUTICAL COMPOSITION AND METHOD OF PREVENTION AND / OR TREATMENT OF ONCOLOGICAL DISEASES

Info

Publication number
EA201600409A1
EA201600409A1 EA201600409A EA201600409A EA201600409A1 EA 201600409 A1 EA201600409 A1 EA 201600409A1 EA 201600409 A EA201600409 A EA 201600409A EA 201600409 A EA201600409 A EA 201600409A EA 201600409 A1 EA201600409 A1 EA 201600409A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pigment
red
armeniaca
penicillium oxalicum
antrakhinon
Prior art date
Application number
EA201600409A
Other languages
Russian (ru)
Other versions
EA028640B1 (en
Inventor
Эдуард Оганестович Сардарян
Original Assignee
Сардарян, Гагик Эдуардович
Сардарян, Гурген Эдуардович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сардарян, Гагик Эдуардович, Сардарян, Гурген Эдуардович filed Critical Сардарян, Гагик Эдуардович
Priority to EA201600409A priority Critical patent/EA028640B1/en
Publication of EA201600409A1 publication Critical patent/EA201600409A1/en
Publication of EA028640B1 publication Critical patent/EA028640B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Предложен способ получения экзогенного красного пигмента, продуцируемого штаммом ЕС гриба Penicillium oxalicum var. Armeniaca, который обладает высокой ингибирующей активностью по отношению к росту опухолевых клеток и не проявляет негативных побочных эффектов на организм человека. Препарат не обладает цитотоксическим и мутагенным эффектом и не накапливается в организме. Полученный продукт с высокой противоопухолевой активностью может применяться в качестве лечебно- профилактического средства для лечения опухолевых заболеваний, таких как рак молочной железы, рак толстой кишки, рак печени, легочной карциномы, хронического лейкоза и обширной гепатоцеллюлярной карциномы.A method of obtaining exogenous red pigment produced by the EU strain of the fungus Penicillium oxalicum var. Armeniaca, which has a high inhibitory activity against the growth of tumor cells and does not show negative side effects on the human body. The drug does not have a cytotoxic and mutagenic effect and does not accumulate in the body. The resulting product with high antitumor activity can be used as a therapeutic and prophylactic agent for treating neoplastic diseases such as breast cancer, colon cancer, liver cancer, pulmonary carcinoma, chronic leukemia and extensive hepatocellular carcinoma.

EA201600409A 2016-06-22 2016-06-22 Red pigment of anthraquinone group, method for producing red pigment of strain of penicillium oxalicum var. armeniaca fungus, product of the method, use thereof, pharmaceutical composition and method for prophylaxis and/or treatment of cancer diseases EA028640B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201600409A EA028640B1 (en) 2016-06-22 2016-06-22 Red pigment of anthraquinone group, method for producing red pigment of strain of penicillium oxalicum var. armeniaca fungus, product of the method, use thereof, pharmaceutical composition and method for prophylaxis and/or treatment of cancer diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201600409A EA028640B1 (en) 2016-06-22 2016-06-22 Red pigment of anthraquinone group, method for producing red pigment of strain of penicillium oxalicum var. armeniaca fungus, product of the method, use thereof, pharmaceutical composition and method for prophylaxis and/or treatment of cancer diseases

Publications (2)

Publication Number Publication Date
EA201600409A1 true EA201600409A1 (en) 2017-11-30
EA028640B1 EA028640B1 (en) 2017-12-29

Family

ID=60421444

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201600409A EA028640B1 (en) 2016-06-22 2016-06-22 Red pigment of anthraquinone group, method for producing red pigment of strain of penicillium oxalicum var. armeniaca fungus, product of the method, use thereof, pharmaceutical composition and method for prophylaxis and/or treatment of cancer diseases

Country Status (1)

Country Link
EA (1) EA028640B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110922379A (en) * 2018-12-04 2020-03-27 福州大学 iso-Penicillium xanthone A from penicillium oxalicum and application in leukemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ97098A3 (en) * 1998-03-30 1999-10-13 Eduard Dr. Sardaryan Strain of penicillium oxalicum var. armeniaca micro-organism and use thereof
CZ289242B6 (en) * 2000-08-10 2001-12-12 Eduard Dr. Sardaryan Preparation exhibiting prophylactic antitumor activity
CZ302696B6 (en) * 2009-11-27 2011-09-07 G.E.S. Biomedical S. R. O. Strain of Penicillium oxalicum var. Armeniaca microscopic fungus and process for preparing magenta

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110922379A (en) * 2018-12-04 2020-03-27 福州大学 iso-Penicillium xanthone A from penicillium oxalicum and application in leukemia

Also Published As

Publication number Publication date
EA028640B1 (en) 2017-12-29

Similar Documents

Publication Publication Date Title
PH12019500521A1 (en) Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
PH12018502429A1 (en) Antibody molecules for cancer treatment
WO2018049152A8 (en) Pyrazolopyrimidine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
AU2016293674B2 (en) A novel approach for treatment of cancer using immunomodulation
PH12017550063A1 (en) Combination therapies for treating cancers
MX2021004639A (en) Combinations of lsd1 inhibitors for use in the treatment of solid tumors.
WO2016025635A3 (en) Combination therapy for treating cancer
WO2017176628A8 (en) Methods for solid tumor treatment
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
WO2016080810A3 (en) Biguanide compound and use thereof
MX2017004661A (en) Cortexolone 17alpha-benzoate for use in the treatment of tumours.
SA515370134B1 (en) Pharmaceutical composition comprising modified hemoglobin- based therapeutic agent for cancer targeting treatment and diagnostic imaging
MD20160016A2 (en) Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same
MX2017015896A (en) Anticancer agent.
WO2016043874A3 (en) Combination therapy for treating cancer
MX2016014436A (en) Heterocyclyl-butanamide derivatives.
MX359656B (en) Oxoquinazolinyl-butanamide derivatives.
WO2016191675A3 (en) Antibodies against glypican-3 and their uses in cancer diagnosis and treatment
PH12019500758A1 (en) Pharmaceutical compositions and methods for the treatment of cancer
MX2020000135A (en) New quinolinone compounds.
MX2022014792A (en) Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same.
MX2018005515A (en) 1,4-dicarbonyl-piperidyl derivatives.
WO2016087932A3 (en) Macromolecular transition metal complexes for treatment of cancer and process for their preparation
EA201600409A1 (en) RED ANTRAKHINON GROUP PIGMENT, METHOD FOR OBTAINING RED STRAIN PIGMENT PENICILLIUM OXALICUM VAR. ARMENIACA, PRODUCT OF THE METHOD, ITS APPLICATION, PHARMACEUTICAL COMPOSITION AND METHOD OF PREVENTION AND / OR TREATMENT OF ONCOLOGICAL DISEASES
MX2019001337A (en) Methods of treating and preventing cancer treatment side effects.

Legal Events

Date Code Title Description
MD4A Opposition filed against granted eurasian patent

Effective date: 20180622

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): TM

QB4A Registration of a licence in a contracting state
NG4A Rejection of opposition against grant of a eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ KG TJ